Listed

Sunshine Biopharma Inc.: Form 10-Q for the period ended Jun 30, 2011

Filed with the SEC on Aug 9, 2011 and accepted by EDGAR at Aug 9, 2011, 17:11 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2011-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2011-04-01 to 2011-06-30$0us-gaap:SalesRevenueGoodsNet
Revenue6 months2011-01-01 to 2011-06-30$0us-gaap:SalesRevenueGoodsNet
Research and development3 months2011-04-01 to 2011-06-30$0us-gaap:ResearchAndDevelopmentExpense
Research and development6 months2011-01-01 to 2011-06-30$17.6kus-gaap:ResearchAndDevelopmentExpense
Net income3 months2011-04-01 to 2011-06-30−$16.5kus-gaap:NetIncomeLoss
Basic EPS3 months2011-04-01 to 2011-06-30−$0.00us-gaap:EarningsPerShareBasic
Basic EPS6 months2011-01-01 to 2011-06-30−$0.00us-gaap:EarningsPerShareBasic
Operating cash flow3 months2011-04-01 to 2011-06-30−$61.1kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2011-06-30$101.2kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2011-06-30$142.5kus-gaap:AssetsCurrent
Total assetsAt period end2011-06-30$142.5kus-gaap:Assets
Total liabilitiesAt period end2011-06-30$0us-gaap:Liabilities

Source: SEC EDGAR, the filing index for accession 0001354488-11-002548. Last ingested by Listed: Nov 14, 2026, 19:46 ET. Listed shows no prices and gives no investment advice.